135 related articles for article (PubMed ID: 6297217)
1. Somatostatinoma syndrome: does a clinical entity exist?
Stacpoole PW; Kasselberg AG; Berelowitz M; Chey WY
Acta Endocrinol (Copenh); 1983 Jan; 102(1):80-7. PubMed ID: 6297217
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-28 like immunoreactivity in normal and tumour tissue from duodenum and pancreas.
Ito S; Yamada Y; Iwanaga T; Kaneko H; Shibata A
Acta Endocrinol (Copenh); 1982 Nov; 101(3):421-7. PubMed ID: 6293233
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcitonemia revealing a somatostatinoma.
Do Cao C; Mekinian A; Ladsous M; Aubert S; D'Herbomez M; Pattou F; Bourdelle-Hego MF; Wémeau JL
Ann Endocrinol (Paris); 2010 Dec; 71(6):553-7. PubMed ID: 20817146
[TBL] [Abstract][Full Text] [Related]
4. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis associated with somatostatinoma: a report of two patients.
Swinburn BA; Yeong ML; Lane MR; Nicholson GI; Holdaway IM
Clin Endocrinol (Oxf); 1988 Apr; 28(4):353-9. PubMed ID: 2903805
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin-Immunoreactive Pancreaticoduodenal Neuroendocrine Neoplasms: Twenty-Three Cases Evaluated according to the WHO 2010 Classification.
Luna IE; Monrad N; Binderup T; Boisen Thoegersen C; Hilsted L; Jensen C; Federspiel B; Knigge U
Neuroendocrinology; 2016; 103(5):567-77. PubMed ID: 26505735
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
8. Comparative diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with a somatostatinoma.
Budmiger H; Bühler H; Häcki W; Stamm B; Streuli R; Ammann R
Gastroenterology; 1987 Mar; 92(3):800-4. PubMed ID: 3028898
[TBL] [Abstract][Full Text] [Related]
9. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
[TBL] [Abstract][Full Text] [Related]
10. Duodenal somatostatinoma with psammoma bodies.
Albrecht S; Gardiner GW; Kovacs K; Ilse G; Kaiser U
Arch Pathol Lab Med; 1989 May; 113(5):517-20. PubMed ID: 2565711
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
[TBL] [Abstract][Full Text] [Related]
12. A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study.
Iguchi H; Hayashi I; Kono A
Cancer Res; 1990 Jun; 50(12):3691-3. PubMed ID: 1971195
[TBL] [Abstract][Full Text] [Related]
13. Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.
Schusdziarra V; Grube D; Seifert H; Galle J; Etzrodt H; Beischer W; Haferkamp O; Pfeiffer EF
Klin Wochenschr; 1983 Jul; 61(14):681-9. PubMed ID: 6136627
[TBL] [Abstract][Full Text] [Related]
14. Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study.
Taccagni GL; Carlucci M; Sironi M; Cantaboni A; Di Carlo V
Am J Gastroenterol; 1986 Jan; 81(1):33-7. PubMed ID: 2867674
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-producing duodenal carcinoma: clinicopathological description of a case.
Masulović D; Stevic R; Filipović A; Micev M; Ivanović A
Acta Chir Iugosl; 2013; 60(3):61-4. PubMed ID: 24669582
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid syndrome due to a malignant somatostatinoma.
Ozbakir O; Keleştimur F; Oztürk F; Sözüer E; Unal A; Patiroğlu TE; Güven K
Postgrad Med J; 1995 Nov; 71(841):695-8. PubMed ID: 7494779
[TBL] [Abstract][Full Text] [Related]
17. [Malignant somatostatinoma--diagnosis after 6 years].
Schaller P; Schweiger M; Stolte M; Lauer E
Leber Magen Darm; 1990 May; 20(3):152-6. PubMed ID: 1974023
[TBL] [Abstract][Full Text] [Related]
18. Duodenal somatostatinoma: a case report and review.
Kim JA; Choi WH; Kim CN; Moon YS; Chang SH; Lee HR
Korean J Intern Med; 2011 Mar; 26(1):103-7. PubMed ID: 21437171
[TBL] [Abstract][Full Text] [Related]
19. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas.
Soga J; Yakuwa Y
J Exp Clin Cancer Res; 1999 Mar; 18(1):13-22. PubMed ID: 10374671
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic somatostatinoma: a case report and review of the literature.
Konomi K; Chijiiwa K; Katsuta T; Yamaguchi K
J Surg Oncol; 1990 Apr; 43(4):259-65. PubMed ID: 1969977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
